An update on the role of thioredoxin-interacting protein in diabetic kidney disease: A mini review

Thioredoxin-interacting protein (TXNIP) was first isolated from Vitamin D3-exposed HL60 cells. TXNIP is the main redox-regulating factor in various organs and tissues. We begin with an overview of the TXNIP gene and protein information, followed by a summary of studies that have shown its expression in human kidneys. Then, we highlight our current understanding of the effect of TXNIP on diabetic kidney disease (DKD) to improve our understanding of the biological roles and signal transduction of TXNIP in DKD. Based on the recent review, the modulation of TXNIP may be considered as a new target in the management of DKD.

[1]  Zheng Liu,et al.  Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus , 2022, Diabetes, metabolic syndrome and obesity : targets and therapy.

[2]  Lili Sun,et al.  Role of Thioredoxin-Interacting Protein in Diabetic Fatty Kidney Induced by Advanced Glycation End-Products. , 2021, Journal of agricultural and food chemistry.

[3]  M. Vaccaro,et al.  Autophagy Dysregulation in Diabetic Kidney Disease: From Pathophysiology to Pharmacological Interventions , 2021, Cells.

[4]  Xiaocheng Zhu,et al.  Effect of Sleeve Gastrectomy on Plasma Thioredoxin-Interacting Protein (TXNIP) , 2021, Obesity Surgery.

[5]  Eman Said,et al.  Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Yan Wang,et al.  Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease , 2021, Frontiers in Pharmacology.

[7]  Tetsuhiro Tanaka,et al.  Update on diagnosis, pathophysiology, and management of diabetic kidney disease , 2021, Nephrology.

[8]  Bingqian Liu,et al.  TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy. , 2021, Life sciences.

[9]  Kaiyan Shao,et al.  Relationships between diabetic nephropathy and insulin resistance, inflammation, Trx, Txnip, CysC and serum complement levels. , 2020, European review for medical and pharmacological sciences.

[10]  Hana Jin,et al.  Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway. , 2020, Biochemical pharmacology.

[11]  T. Jin,et al.  Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein , 2020, American journal of physiology. Endocrinology and metabolism.

[12]  P. Sethupathy,et al.  Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action. , 2020, Cell metabolism.

[13]  Z. Varghese,et al.  Non-esterified free fatty acids (NEFA) enhance the inflammatory response in renal tubules by inducing extracellular ATP release. , 2020, American journal of physiology. Renal physiology.

[14]  Li-hua Hu,et al.  TXNIP Gene Single Nucleotide Polymorphisms Associate with the Risk of Type 2 Diabetes Mellitus in a Chinese Han Population. , 2020, DNA and cell biology.

[15]  Jihua Chen,et al.  Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway , 2020, Nutrients.

[16]  Ming Zhang,et al.  TXNIP hypomethylation and its interaction with obesity and hypertriglyceridemia increase type 2 diabetes mellitus risk: A nested case‐control study , 2020, Journal of diabetes.

[17]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[18]  G. Qin,et al.  FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX , 2019, Oxidative medicine and cellular longevity.

[19]  H. Duan,et al.  Thioredoxin‐interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy , 2019, Journal of cellular physiology.

[20]  A. Shalev,et al.  Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP , 2018, Current opinion in endocrinology, diabetes, and obesity.

[21]  Lin Sun,et al.  Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis , 2018, Redox biology.

[22]  N. Mizushima,et al.  Monitoring and Measuring Autophagy , 2017, International journal of molecular sciences.

[23]  H. Chung,et al.  Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome. , 2017, The Journal of nutritional biochemistry.

[24]  A. Levin,et al.  Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats , 2017, Nutrients.

[25]  Yan Wang,et al.  Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  I. Pedrosa,et al.  Quantification of renal steatosis in type II diabetes mellitus using dixon‐based MRI , 2016, Journal of magnetic resonance imaging : JMRI.

[27]  H. Duan,et al.  Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease. , 2016, The international journal of biochemistry & cell biology.

[28]  G. Liou,et al.  Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome. , 2016, Life sciences.

[29]  Yuan Zhang,et al.  Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway , 2016, Scientific Reports.

[30]  P. Hu,et al.  The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. , 2016, Journal of the American Society of Nephrology : JASN.

[31]  L. Groop,et al.  Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. , 2016, Kidney international.

[32]  D. Giannella‐Neto,et al.  Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes , 2016, Free radical research.

[33]  Merlin C. Thomas,et al.  Diabetic kidney disease , 2015, Nature Reviews Disease Primers.

[34]  I. G. Fantus,et al.  Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[35]  Soo-Hyun Park,et al.  Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo. , 2014, Journal of hepatology.

[36]  H. Lamb,et al.  Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. , 2014, The lancet. Diabetes & endocrinology.

[37]  F. Braet,et al.  Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux , 2014, Laboratory Investigation.

[38]  A. Tobar,et al.  Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy , 2014, Journal of Lipid Research.

[39]  K. Block,et al.  Nox as a target for diabetic complications. , 2013, Clinical science.

[40]  Carly R. Kibbe,et al.  FOXO1 Competes with Carbohydrate Response Element-binding Protein (ChREBP) and Inhibits Thioredoxin-interacting Protein (TXNIP) Transcription in Pancreatic Beta Cells* , 2013, The Journal of Biological Chemistry.

[41]  Richard T. Lee,et al.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. , 2013, Antioxidants & redox signaling.

[42]  Yan Luo,et al.  A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. , 2012, Cellular signalling.

[43]  A. Vercesi,et al.  Mitochondria and reactive oxygen species. , 2009, Free radical biology & medicine.

[44]  Yuan Zhang,et al.  Expression, localization, and function of the thioredoxin system in diabetic nephropathy. , 2009, Journal of the American Society of Nephrology : JASN.

[45]  A. Murdoch.  Cloning , 2007, Ethics & Medics.

[46]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[47]  Richard T. Lee,et al.  The Interaction of Thioredoxin with Txnip , 2006, Journal of Biological Chemistry.

[48]  P. Bohlen,et al.  Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene. , 2001, Gene.

[49]  M. Matsui,et al.  Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression* , 1999, The Journal of Biological Chemistry.

[50]  H. DeLuca,et al.  Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. , 1994, Biochimica et biophysica acta.

[51]  喬 嶋本.  Nested Case-control Study , 1992, Definitions.

[52]  Yuan Zhang,et al.  Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  M. A. Wouters,et al.  Disulfides as redox switches: from molecular mechanisms to functional significance. , 2010, Antioxidants & redox signaling.

[54]  P. D. de Jong,et al.  Positional cloning of the combined hyperlipidemia gene Hyplip1 , 2002, Nature genetics.